Novel therapeutic strategies for advanced ovarian cancer by using induced pluripotent stem cell‐derived myelomonocytic cells producing interferon beta

Although first‐line chemotherapy has a high rate of complete responses in ovarian cancer patients, the vast majority of patients present with recurrent disease that has become refractory to conventional chemotherapy. Peritoneal dissemination and malignant ascites are the hallmarks of recurrent or ad...

Descripción completa

Detalles Bibliográficos
Autores principales: Imamura, Yuko, Tashiro, Hironori, Tsend‐Ayush, Gandolgor, Haruta, Miwa, Dashdemberel, Narantuya, Komohara, Yoshihiro, Tsuboki, Junko, Takaishi, Kiyomi, Ohba, Takashi, Nishimura, Yasuharu, Katabuchi, Hidetaka, Senju, Satoru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6215869/
https://www.ncbi.nlm.nih.gov/pubmed/30142694
http://dx.doi.org/10.1111/cas.13775

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6215869/
https://www.ncbi.nlm.nih.gov/pubmed/30142694
http://dx.doi.org/10.1111/cas.13775

Ejemplares similares